Abstract
Background/Objectives:
Colonic fermentation of dietary fibre produces short-chain fatty acids (SCFAs), acetate, propionate and butyrate, which may protect against type 2 diabetes by reducing serum free-fatty acids (FFAs). Since hyperinsulinaemia is associated with insulin resistance and increased diabetes risk, the main objective was to compare markers of colonic fermentation after acute inulin ingestion in subjects with normal (<40 pmol/l, NI) and high (⩾40 pmol/l, HI) plasma insulin.
Subjects/Methods:
Overnight fasted NI (n=9) and HI (n=9) subjects were studied for 4 h on two separate days after consuming 300 ml drinks containing 75 g glucose (Glucose) or 75 g glucose plus 24 g inulin (Inulin) using a randomized, single-blind, crossover design.
Results:
Inulin elicited a higher breath hydrogen and methane areas under the curve (AUC), but the increases in SCFA responses were not statistically significant. Mean serum-acetate concentration over the 4-h study period was higher in NI than in HI subjects (44.3±6.9 vs 22.5±3.7 μmol/l, P=0.001). The rate of rebound of FFA was reduced by Inulin, with FFA at 4 h being less after Inulin than Glucose, regardless of insulin status (0.310±0.028 vs 0.432±0.042 mEq/l, P=0.008).
Conclusions:
This suggests that inulin increases short-term markers for colonic fermentation, but a longer study period may be necessary to observe differences in SCFA production. The reason for the lower serum acetate in HI is unclear but may be due to reduced absorption, increased clearance or decreased endogenous production. This suggests the need to compare acetate kinetics in normal and hyperinsulinaemic subjects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akanji AO, Humphreys S, Thursfield V, Hockaday TD (1989). The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects. Clin Chim Acta 185, 25–34.
Boden G (2002). Interaction between free fatty acids and glucose metabolism. Curr Opin Nutr Metab Care 5, 545–549.
Boden G, Shulman GI (2002). Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and B-cell dysfunction. Eur J Clin Invest 32, S14–S23.
Brighenti F, Benini L, Del Rio D, Casiraghi C, Pellegrini N, Scazzina F (2006). Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. Am J Clin Nutr 83, 817–822.
Caballero B (2007). The global epidemic of obesity: an overview. Epidemiol Rev 29, 1–5.
Crouse JR, Gerson CD, Decarli LM, Lieber S (1968). Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J Lipid Res 9, 509–512.
Del Boca J, Flatt JP (1969). Fatty acid synthesis from glucose and acetate and the control of lipogenesis in adipose tissue. Eur J Biochem 11, 127–134.
de Munter JSL, Hu FB, Spiegelman D, Franz M, van Dam RM (2007). Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4, 1385–1394.
Ferchaud-Roucher V, Pouteau E, Piloquet H, Zaïr Y, Krempf M (2005). Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. Am J Physiol Endocrinol Metab 289, E716–E720.
Freeland KR, Wilson C, Wolever TMS (2009). Adaptation of colonic fermentation and glucagon-like peptide-1 (GLP-1) secretion with increased wheat fibre intake for 1-year in hyperinsulinaemic humans. Br J Nutr 103, 82–90.
Gibson GR, Beatty ER, Wang X, Cummings JH (1995). Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
Greenberg AS, McDaniel ML (2002). Identifying the links between obesity, insulin resistance and β-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 (Suppl 3), 24–34.
Jenkins DJA, Wolever TMS, Jenkins A, Brighenti F, Vuksan V, Rao AV et al. (1991). Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am J Clin Nutr 54, 141–147.
Knowles SE, Jarrett IG, Filsell OH, Ballard FJ (1974). Production and utilization of acetate in mammals. Biochem J 142, 401–411.
Liese AD, Schulz M, Fang F, Wolever TMS, D’Agostino Jr RB, Sparks KC (2005). Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study. Diabetes Care 28, 2832–2838.
Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE et al. (1999). Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health Study. Am J Clin Nutr 70, 412–419.
Luong A, Hannah V, Brown M, Goldstein J (2000). Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem 275, 458–466.
McGarry JD (2002). Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7–18.
Piloquet H, Ferchaud-Roucher V, Duengler F, Zair Y, Maugere P, Krempf M (2003). Insulin effects on acetate metabolism. Am J Physiol Endocrinol Metab 285, E561–E565.
Popkin BM, Gordon-Larsen P (2004). The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord 28 (Suppl), S2–S9.
Prentki M, Nolan CJ (2006). Islet β cell failure in type 2 diabetes. J Clin Invest 116, 1802–1812.
Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN (2005). Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82, 559–567.
Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN (2003). Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46, 659–665.
Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S et al. (2005). Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 71, 6150–6158.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997). Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472–477.
Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H (2007). Fiber and magnesium intake and incidence of type 2 diabetes. A prospective study and meta-analysis. Arch Intern Med 167, 956–965.
Sone H, Shimano H, Sakakura Y, Inoue N, Amemiya-Kudo M, Yahagi N et al. (2002). Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am J Physiol Endocrinol Metab 282, E222–E230.
Tarini J, Wolever TMS (2010). The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35, 9–16.
Todesco T, Zamboni M, Armellini F, Bissoli L, Turcato E, Piemonte G et al. (1993). Plasma acetate levels in a group of obese diabetic, obese normoglycemic, and control subjects and their relationships with other blood parameters. Am J Gastroenterol 88, 751–755.
Tollinger CD, Vreman HJ, Wiener MW (1979). Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding and various diseases. Clin Chem 25, 1787–1790.
Weickert MO, Mohlig M, Koebnick C, Holst JJ, Namsolleck P, Ristow M et al. (2005). Impact of cereal fibre on glucose-regulating factors. Diabetologia 48, 2343–2353.
Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053.
Wolever TM, Josse RG, Leiter LA, Chiasson JL (1997). Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805–811.
Wolever TM, Radmard R, Chiasson J-L, Hunt JA, Josse RG, Palmason C et al. (1995). One-year acarbose therapy raises fasting serum acetate in diabetic patients. Diabet Med 12, 164–172.
Wolever TMS, Brighenti F, Royall D, Jenkins AL, Jenkins DJA (1989). Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 84, 1027–1033.
World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. World Health Organization: Geneva. (WHO technical report series 894).
Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM (2000). Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23, 171–175.
Acknowledgements
This work was supported by a grant from the Canadian Institutes for Health Research, Institute of Nutrition, Metabolism and Diabetes.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Fernandes, J., Vogt, J. & Wolever, T. Inulin increases short-term markers for colonic fermentation similarly in healthy and hyperinsulinaemic humans. Eur J Clin Nutr 65, 1279–1286 (2011). https://doi.org/10.1038/ejcn.2011.116
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.116
Keywords
This article is cited by
-
Cereal fructan extracts alter intestinal fermentation to reduce adiposity and increase mineral retention compared to oligofructose
European Journal of Nutrition (2019)
-
The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans
European Journal of Clinical Nutrition (2017)
-
The metabolic fate of acetate in cancer
Nature Reviews Cancer (2016)
-
1H NMR based metabolomic approach to monitoring of the head and neck cancer treatment toxicity
Metabolomics (2016)
-
Kinetic model of acetate metabolism in healthy and hyperinsulinaemic humans
European Journal of Clinical Nutrition (2014)